Risk Stratification-directed Therapy for AML With t(8;21) /AML1-ETO+
Conditions
- Acute Myeloid Leukemia
- Risk Stratification
Interventions
- OTHER: Consolidation with chemotherapy (CT) or autologous hematopoietic stem cell transplantation (auto-HSCT)
- OTHER: Consolidation with auto-HSCT or HLA-matched HSCT
- OTHER: allogeneic HSCT
Sponsor
Nanfang Hospital, Southern Medical University
Collaborators